Poseida Therapeutics Named to Newsweek's List of the Top 200 America's Most Loved Workplaces for 2024

Provided By PR Newswire

Last update: Oct 3, 2024

Inclusion on list recognizes Poseida for employee sentiment and satisfaction

SAN DIEGO, Oct. 3, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments for patients with cancer and rare diseases, today announced its inclusion in Newsweek Magazine's annual America's Top Most Loved Workplaces^® list, developed by Most Loved Workplace^®, a division of Best Practice Institute (BPI).